River Wealth Advisors LLC raised its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 3.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,190 shares of the pharmacy operator’s stock after purchasing an additional 279 shares during the period. River Wealth Advisors LLC’s holdings in Walgreens Boots Alliance were worth $641,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Nordea Investment Management AB raised its position in shares of Walgreens Boots Alliance by 26.5% in the 1st quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock worth $760,267,000 after acquiring an additional 1,917,082 shares in the last quarter. Wellington Management Group LLP raised its position in shares of Walgreens Boots Alliance by 5.9% in the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock worth $2,727,932,000 after acquiring an additional 1,824,300 shares in the last quarter. TIAA CREF Investment Management LLC raised its position in shares of Walgreens Boots Alliance by 22.4% in the 1st quarter. TIAA CREF Investment Management LLC now owns 5,269,500 shares of the pharmacy operator’s stock worth $437,632,000 after acquiring an additional 962,959 shares in the last quarter. UBS Asset Management Americas Inc. raised its position in shares of Walgreens Boots Alliance by 22.9% in the 1st quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock worth $407,982,000 after acquiring an additional 914,888 shares in the last quarter. Finally, Prudential Financial Inc. raised its position in shares of Walgreens Boots Alliance by 53.0% in the 1st quarter. Prudential Financial Inc. now owns 2,211,112 shares of the pharmacy operator’s stock worth $183,632,000 after acquiring an additional 766,200 shares in the last quarter. 60.16% of the stock is owned by institutional investors and hedge funds.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at 78.41 on Friday. The stock has a market cap of $83.91 billion, a price-to-earnings ratio of 19.80 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a one year low of $75.18 and a one year high of $89.69. The company has a 50 day moving average price of $81.36 and a 200-day moving average price of $81.86.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The firm had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. During the same quarter last year, the company posted $1.18 EPS. The firm’s quarterly revenue was up 2.1% on a year-over-year basis. Equities analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current fiscal year.

Walgreens Boots Alliance announced that its Board of Directors has approved a stock buyback program on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to purchase up to 5.9% of its stock through open market purchases. Stock buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.04%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date was Wednesday, August 16th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 40.30%.

A number of research firms recently weighed in on WBA. Needham & Company LLC set a $94.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Monday, July 17th. Pivotal Research set a $85.00 target price on Walgreens Boots Alliance and gave the company a “hold” rating in a research note on Sunday, July 2nd. Guggenheim reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $77.00 target price (down from $89.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, June 28th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and fifteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of $92.06.

In other news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total value of $218,305.44. Following the sale, the director now directly owns 19,151 shares in the company, valued at approximately $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 13.50% of the stock is currently owned by company insiders.

COPYRIGHT VIOLATION WARNING: This story was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-holdings-lifted-by-river-wealth-advisors-llc/1583958.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.